PDF(Pubmed)
Abstract：
Korean medicine (KM) is used to treat anxiety disorders, but there is limited research on its effects. This study aimed to examine the associations between improved QoL and reduced clinical symptoms and KM in patients with anxiety disorders. The medical records of patients with anxiety who were treated with KM (acupuncture, psychotherapy, Chuna therapy, aromatherapy, or herbal medicine) for at least 4 weeks were retrospectively analyzed. Clinical, QoL, and cost outcomes were measured at baseline and at weeks 4 and 12 (Anxiety: State-Trait Anxiety Inventory [STAI X-1 (state), X-2 (trait)], Beck Anxiety Inventory [BAI]; anger: State-Trait Anger Expression Inventory State [STAXI-S (state), T (trait)], Anger Expression Inventory [AXI-K-I (anger-in), AXI-K-O (anger-out), AXI-K-C (anger-control); depression: Beck Depression Inventory-II [BDI II], QoL: QoL-related instruments Euro Quality of Life 5 Dimensions utility score [EQ-5D], Euro QoL Visual Analog Scale [EQ-VAS]). The total costs for each item were calculated in terms of NHIS-covered costs and patients\' out-of-pocket costs from the perspective of the healthcare system. The medical records of 67 patients were evaluated. The KM treatments were found to be associated with decreased anxiety (STAI X-1; STAI X-2; BAI, p < 0.0001), depression (BDI-II, p < 0.0001), and anger (AKI-K-I; AKI-K-O, p < 0.05) and increased QoL (EQ-5D; EQ-VAS, p < 0.0001). An average of USD 1360 was paid for the KM treatments for 4 weeks. The study findings suggested that KM may improve clinical symptoms and QoL outcomes in patients with anxiety disorders.
摘要：
韩国医学（KM）用于治疗焦虑症，但对其影响的研究有限。这项研究旨在研究焦虑症患者的QoL改善和临床症状减少与KM之间的关联。接受KM治疗的焦虑症患者的病历（针灸，心理治疗,Chuna疗法,芳香疗法,或草药）至少4周的回顾性分析。临床,QoL,和成本结果在基线和第4周和第12周测量(焦虑：状态-特质焦虑量表[STAIX-1(状态)，X-2（性状）]，贝克焦虑量表[BAI]；愤怒：状态特征愤怒表情量表状态[STAXI-S（状态），T（性状）]，愤怒表情清单[AXI-K-I（愤怒），AXI-K-O（愤怒），AXI-K-C(愤怒控制)；抑郁症：贝克抑郁量表-II[BDIII]，QoL：QoL相关工具欧洲生活质量5维度效用评分[EQ-5D]，欧洲QoL视觉模拟量表[EQ-VAS])。从医疗保健系统的角度来看，每个项目的总费用是根据NHIS覆盖的费用和患者自付费用计算的。评估了67例患者的病历。发现KM治疗与焦虑降低相关(STAIX-1；STAIX-2；BAI，p<0.0001),抑郁症（BDI-II，p<0.0001),和愤怒(AKI-K-I；AKI-K-O，p<0.05)和增加的QoL(EQ-5D；EQ-VAS，p<0.0001)。为4周的KM治疗平均支付1360美元。研究结果表明，KM可以改善焦虑症患者的临床症状和QoL结果。
